Commissioner Defends FDA On Duodenoscope, LDT Actions At Senate Hearing
This article was originally published in The Gray Sheet
Executive Summary
In her last appearance before a Senate committee March 10, FDA Commissioner Margaret Hamburg presented a strong defense of FDA’s actions to address contaminated duodenoscopes, regulation of lab developed tests and other hot button issues raised by Senators, who also praised her leadership at FDA.